How would you define the success of ConnectiveRx's Electronic Prior Authorization platform?

Introduction

Defining the success of ConnectiveRx's Electronic Prior Authorization (ePA) platform requires a comprehensive approach that considers multiple stakeholders and metrics. To address this product success metrics challenge effectively, I'll follow a structured framework covering core metrics, supporting indicators, and risk factors while considering all key stakeholders.

Step 1

Product Context

ConnectiveRx's Electronic Prior Authorization platform is a digital solution designed to streamline the prior authorization process for prescription medications. It connects healthcare providers, pharmacies, and insurance companies to expedite approvals for medications that require pre-authorization.

Key stakeholders include:

1. Healthcare providers: Seeking faster approvals and reduced administrative burden
2. Patients: Desiring quicker access to needed medications
3. Insurance companies: Aiming for efficient processing and cost control
4. Pharmacies: Looking to reduce delays in dispensing medications
5. ConnectiveRx: Focused on platform adoption and revenue growth

User flow:

1. Provider initiates ePA request through EHR or ConnectiveRx portal
2. Platform routes request to appropriate insurer with required documentation
3. Insurer reviews and responds electronically
4. Provider and pharmacy receive decision, with automated follow-ups if needed

The ePA platform aligns with ConnectiveRx's broader strategy of improving medication access and adherence through technology-enabled solutions. Compared to competitors, ConnectiveRx's platform may offer wider integration capabilities or more advanced analytics.

Product Lifecycle Stage: The ePA platform is likely in the growth stage, with increasing adoption but still room for expansion and feature enhancement.